ICAM1 and neoplasm: Due to cross-reactivity of our CAR T cells between human and mouse ICAM-1, the lack of on-target, off-tumor toxicity by micromolar affinity CAR T cells in mice with human tumor xenografts could be used to support specificity of our CAR T cells toward ICAM-1 high tumors in humans.